[{"id":"eba3f2d8-df2f-4db2-8b50-7d1ebd4b5a6b","acronym":"","url":"https://clinicaltrials.gov/study/NCT04368182","created_at":"2021-06-30T14:53:52.902Z","updated_at":"2024-07-02T16:36:45.519Z","phase":"Phase 1","brief_title":"AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma","source_id_and_acronym":"NCT04368182","lead_sponsor":"Zhejiang University","biomarkers":" HLA-A • AFP","pipe":" | ","alterations":" HLA-A*02 • AFP expression","tags":["HLA-A • AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02 • AFP expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e C-TCR055"],"overall_status":"Unknown status","enrollment":" Enrollment 3","initiation":"Initiation: 04/13/2020","start_date":" 04/13/2020","primary_txt":" Primary completion: 08/31/2020","primary_completion_date":" 08/31/2020","study_txt":" Completion: 11/30/2021","study_completion_date":" 11/30/2021","last_update_posted":"2020-04-29"},{"id":"182788c6-1780-477a-87bc-0e5bf73a6189","acronym":"","url":"https://clinicaltrials.gov/study/NCT03971747","created_at":"2021-06-30T14:53:40.918Z","updated_at":"2024-07-02T16:36:46.431Z","phase":"Phase 1","brief_title":"AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma","source_id_and_acronym":"NCT03971747","lead_sponsor":"Cellular Biomedicine Group Ltd.","biomarkers":" HLA-A • AFP","pipe":" | ","alterations":" HLA-A*02 • AFP expression","tags":["HLA-A • AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02 • AFP expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e C-TCR055"],"overall_status":"Unknown status","enrollment":" Enrollment 9","initiation":"Initiation: 08/06/2019","start_date":" 08/06/2019","primary_txt":" Primary completion: 06/01/2020","primary_completion_date":" 06/01/2020","study_txt":" Completion: 04/01/2021","study_completion_date":" 04/01/2021","last_update_posted":"2020-04-07"}]